MYCENAX BIOTECH INC. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 48.55 TWD | +5.43% |
|
+15.05% | +35.99% |
| 05-15 | Mycenax Biotech Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
| 03-14 | Mycenax Biotech Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Compared values
| Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| MYCENAX BIOTECH INC. | Bio Therapeutic Drugs | +5.43% | +15.05% | +35.99% | +23.85% | +108.37% | 293M |  |  | |
Technical Rankings Surperformance
- Stock Market
- Equities
- 4726 Stock
- Charts Mycenax Biotech Inc.
- Comparison Chart
